Negative Perceptions of Cancer Clinical Trials Persist

The Cancer Support Community (CSC), a nonprofit organization, recently announced the results of its studies regarding perceptions of clinical trials among cancer survivors during the 2017 American Psychological Association Annual Convention.

From a study of over 3000 participants, results showed that negative perceptions of clinical trials and low participation in trials still persist. Furthermore, these barriers are heightened within racial and ethnic minorities.

• 61% reported feeling uncomfortable about being randomly assigned a treatment
• 57% expressed fear they would receive a placebo
• 24% believe their insurance would not cover the cost of a clinical trial
• 18% thought that logistical barriers (like transportation), makes it impossible to fulfill trial requirements

Within ethnic monitories, including Black and African American, Asian and Hispanic participants reported a greater mistrust and lack of understanding of clinical trials.

Joanne Buzaglo, Ph.D., Senior Vice President of Research and Training at CSC, explained that “Clinical trials are essential for advancing cancer research of treatment and finding a cure. However, fewer than five percent of adults with cancer participate in trials nationally,” and “To increase participation rates, we must ramp up outreach efforts to racial and ethnic minority groups because having diversity in trials increases the generalizability of the results.”

For the full press release from the CSC, click here.

Leave a Comment